Alto Neuroscience (Alto Neuroscience) Accounts Payable & Accrued Expense : $6.81 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Accounts Payable & Accrued Expense?

Alto Neuroscience's quarterly accounts payable & accrued expense declined from Sep. 2023 ($5.60 Mil) to Dec. 2023 ($5.49 Mil) but then increased from Dec. 2023 ($5.49 Mil) to Mar. 2024 ($6.81 Mil).

Alto Neuroscience's annual accounts payable & accrued expense increased from Dec. 2021 ($1.81 Mil) to Dec. 2022 ($5.28 Mil) and increased from Dec. 2022 ($5.28 Mil) to Dec. 2023 ($5.49 Mil).

Alto Neuroscience Accounts Payable & Accrued Expense Historical Data

The historical data trend for Alto Neuroscience's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Accounts Payable & Accrued Expense Chart

Alto Neuroscience Annual Data

Trend

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

1.81

5.28

5.49

Alto Neuroscience Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			5.28	-	5.60	5.49	6.81

Alto Neuroscience Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Alto Neuroscience (Alto Neuroscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus

Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc

By GuruFocus Research • 02-08-2024